Sign inJoin waitlistJoin the waitlist

Mahvish Muzaffar

Program Director, Hematology/Oncology Fellowship · ECU Health Medical Center

Credentials: · · · ·

History

Hematology/Oncology Fellowship · ECU Health Medical Center
Present
ECU Health Medical Center
Present

University Medical Center
2013–2015
Hematology and Medical Oncology
University of Toledo
2010–2013
Sheri Kashmir Institute of Medical Sciences
2001–2006
Internal Medicine
University Medical Center
1998–2001
Kazakh National Medical University
1994–1998

Research

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study
Hepatology · 2022 · 215 citations
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
Journal of Clinical Oncology · 2024 · 89 citations
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
Cancers · 2021 · 75 citations

Abdul Naqash
19 papers · 6 as a fellow
AS
Anwaar Saeed
15 papers
Celina Ang
15 papers
Thomas Marron
13 papers
Ahmed Kaseb
12 papers
Hannah Hildebrand
12 papers · 6 as a resident
Uqba Khan
10 papers · 3 as a fellow
Yinghong Wang
10 papers
Nasreen Vohra
9 papers
SD
Sirish Dharmapuri
9 papers
Suneetha Amara
9 papers · 9 as a fellow
TJ
Tomi Jun
9 papers · 6 as a fellow

Clinical trials

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2028
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2022–2027
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2020–2026